Evidence map›Paper›PMID 17097148›Full record

ReviewPharmacology & therapeutics2007

The role of intracellular signaling in insulin-mediated regulation of drug metabolizing enzyme gene and protein expression.

Sang K Kim, Raymond F Novak

Open access · greenAbstract readReview
In one paragraph

Review in Pharmacology & therapeutics, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 161 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Sang K KimInstitute of Environmental Health Sciences, Wayne State University, 2727 Second Avenue, Room 4000, Detroit, MI 48201, USA.
Raymond F Novak
Chungnam National University · KRWayne State University · US

Funding

RESEARCH CORE-- SIGNAL TRANSDUCTIONP30ES006639 · NIEHS · WAYNE STATE UNIVERSITY · PI DERESKI, MARY O · 1994 to 2008
$13.1M
NITROGEN HETEROCYCLES: METABOLIC EFFECTS AND TOXICITYR01ES003656 · NIEHS · WAYNE STATE UNIVERSITY · PI NOVAK, RAYMOND F · 1987 to 2010
$2.3M
NIEHS NIH HHS ES03656NIEHS NIH HHS P30 ES006639NIEHS NIH HHS P30 ES006639-13NIEHS NIH HHS P30 ES06639NIEHS NIH HHS R01 ES003656NIEHS NIH HHS R01 ES003656-17
6 · The paper itself

Abstract

Endogenous factors, including hormones, growth factors and cytokines, play an important role in the regulation of hepatic drug metabolizing enzyme expression in both physiological and pathophysiological conditions. Diabetes, fasting, obesity, protein-calorie malnutrition and long-term alcohol consumption produce changes in hepatic drug metabolizing enzyme gene and protein expression. This difference in expression alters the metabolism of xenobiotics, including procarcinogens, carcinogens, toxicants and therapeutic agents, potentially impacting the efficacy and safety of therapeutic agents, and/or resulting in drug-drug interactions. Although the mechanisms by which xenobiotics regulate drug metabolizing enzymes have been studied intensively, less is known regarding the cellular signaling pathways and components which regulate drug metabolizing enzyme gene and protein expression in response to hormones and cytokines. Recent findings, however, have revealed that several cellular signaling pathways are involved in hormone- and growth factor-mediated regulation of drug metabolizing enzymes. Our laboratory has reported that insulin and growth factors regulate drug metabolizing enzyme gene and protein expression, including cytochromes P450 (CYP), glutathione S-transferases (GST) and microsomal epoxide hydrolase (mEH), through receptors which are members of the large receptor tyrosine kinase (RTK) family, and by downstream effectors such as phosphatidylinositol 3-kinase, mitogen activated protein kinase (MAPK), Akt/protein kinase B (PKB), mammalian target of rapamycin (mTOR), and the p70 ribosomal protein S6 kinase (p70S6 kinase). Here, we review current knowledge of the signaling pathways implicated in regulation of drug metabolizing enzyme gene and protein expression in response to insulin and growth factors, with the goal of increasing our understanding of how disease affects these signaling pathways, components, and ultimately gene expression and translational control.

Indexed as

Gene Expression Regulation, EnzymologicSignal TransductionAnimalsCytochrome P-450 Enzyme SystemEpoxide HydrolasesGlutamate-Cysteine LigaseGlutathione TransferaseHumansHypoglycemic AgentsInsulinIntercellular Signaling Peptides and ProteinsIsoenzymesLiverMAP Kinase Signaling SystemMetabolic Detoxication, Phase IIPhosphoric Monoester HydrolasesCytochrome P-450 Enzyme SystemEpoxide HydrolasesGlutamate-Cysteine LigaseGlutathione TransferaseHypoglycemic AgentsInsulinIntercellular Signaling Peptides and ProteinsIsoenzymesPhosphoric Monoester HydrolasesReceptor, InsulinReceptors, Growth Factor

Identifiers

PMID17097148
PMCPMC1828071
OpenAlexW2073526315

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.